Tevogen, Inc. (TVGN)
7.30
-0.06
(-0.82%)
USD |
NASDAQ |
Sep 14, 09:51
Tevogen Price : 7.30 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 6.97 | 7.90 | 6.97 | 7.36 | 72675.00 |
| Sep 10, 2026 | 7.264 | 7.29 | 7.038 | 7.29 | 2490.00 |
| Sep 09, 2026 | 7.215 | 7.34 | 7.10 | 7.34 | 4079.00 |
| Sep 08, 2026 | 7.32 | 7.33 | 6.96 | 7.33 | 3168.00 |
| Sep 04, 2026 | 7.124 | 7.34 | 6.935 | 7.34 | 1961.00 |
| Sep 03, 2026 | 7.165 | 7.17 | 6.90 | 7.17 | 5562.00 |
| Sep 02, 2026 | 7.00 | 7.17 | 7.00 | 7.17 | 1507.00 |
| Sep 01, 2026 | 6.725 | 7.17 | 6.72 | 7.17 | 2747.00 |
| Aug 31, 2026 | 6.80 | 6.98 | 6.80 | 6.98 | 8549.00 |
| Aug 28, 2026 | 6.55 | 6.93 | 6.55 | 6.89 | 2625.00 |
| Aug 27, 2026 | 6.70 | 6.76 | 6.70 | 6.75 | 3477.00 |
| Aug 26, 2026 | 6.79 | 6.79 | 6.65 | 6.70 | 1918.00 |
| Aug 25, 2026 | 6.62 | 6.97 | 6.531 | 6.97 | 2622.00 |
| Aug 24, 2026 | 6.44 | 6.90 | 6.44 | 6.81 | 4700.00 |
| Aug 21, 2026 | 6.225 | 6.87 | 6.225 | 6.75 | 13040.00 |
| Aug 20, 2026 | 6.335 | 6.41 | 6.335 | 6.37 | 3048.00 |
| Aug 19, 2026 | 6.50 | 6.50 | 6.00 | 6.42 | 9112.00 |
| Aug 18, 2026 | 6.37 | 6.37 | 6.074 | 6.31 | 8876.00 |
| Aug 17, 2026 | 6.66 | 6.72 | 6.498 | 6.58 | 5874.00 |
| Aug 14, 2026 | 5.90 | 6.87 | 5.90 | 6.87 | 8214.00 |
| Aug 13, 2026 | 6.52 | 6.590 | 6.315 | 6.57 | 5847.00 |
| Aug 12, 2026 | 6.81 | 6.870 | 6.29 | 6.47 | 12302.00 |
| Aug 11, 2026 | 6.205 | 6.65 | 6.205 | 6.65 | 6862.00 |
| Aug 10, 2026 | 6.28 | 6.52 | 6.03 | 6.39 | 6713.00 |
| Aug 07, 2026 | 6.34 | 6.63 | 5.925 | 6.47 | 10822.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 83.15 |
| Oncolytics Biotech, Inc. | 0.7659 |
| Sangamo Therapeutics, Inc. | 0.1485 |
| Sarepta Therapeutics, Inc. | 21.19 |
| Anixa Biosciences, Inc. | 2.80 |
Price Related Metrics
| PEG Ratio | -0.0330 |
| Earnings Yield | -79.88% |
| Market Cap | 31.06M |
| PEGY Ratio | -0.0330 |